Is critical care ready for an economic surrogate endpoint?

被引:10
|
作者
Wilcox, M. Elizabeth [1 ,2 ]
Rubenfeld, Gordon D. [2 ,3 ,4 ]
机构
[1] Univ Hlth Network, Toronto Western Hosp, Dept Med, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Interdept Div Crit Care, Toronto, ON M4N 3M5, Canada
[3] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada
[4] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
来源
CRITICAL CARE | 2015年 / 19卷
关键词
LENGTH-OF-STAY; INTENSIVE-CARE; COST-EFFECTIVENESS; IMPACT;
D O I
10.1186/s13054-015-0947-0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Intensive care is expensive, and thus a body of research has focused on strategies to reduce its costs. However, efforts to reduce the total cost of intensive care have met with limited success, partly because of the challenges of calculating how much a day in the ICU actually costs. We discuss these challenges and introduce the concept of total cost savings as an outcome of critical care trials, assuming statistically negative effects on mortality and quality of life.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Is critical care ready for an economic surrogate endpoint?
    M Elizabeth Wilcox
    Gordon D Rubenfeld
    Critical Care, 19
  • [2] Are you ready to move into critical care?
    Cottrell, Damon
    Kendall, Stephanie M.
    AMERICAN JOURNAL OF NURSING, 2010, : 20 - 21
  • [3] Change in albuminuria as a surrogate endpoint
    Waijer, Simke W.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06): : 519 - 526
  • [4] Establishing and Using Threshold of Surrogate Endpoint in Relation to Clinical Endpoint
    Cheng, Yu-Chieh
    Tsou, Hsiao-Hui
    Hung, H. M. James
    Fan, Byron
    Fan, Brandon
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024,
  • [5] Transformation: are nurse leaders in critical care ready?
    Botma, Yvonne
    Botha, Hanlie
    Nel, Mariette
    JOURNAL OF NURSING MANAGEMENT, 2012, 20 (07) : 921 - 927
  • [6] Clinical potential of microdystrophin as a surrogate endpoint
    Boehler, Jessica F.
    Brown, Kristy J.
    Beatka, Margaret
    Gonzalez, J. Patrick
    Dreghici, Roxana Donisa
    Soustek-Kramer, Meghan
    McGonigle, Sharon
    Ganot, Annie
    Palmer, Timothy
    Lowie, Caitlin
    Chamberlain, Jeffrey S.
    Lawlor, Michael W.
    Morris, Carl A.
    NEUROMUSCULAR DISORDERS, 2023, 33 (01) : 40 - 49
  • [7] pCR Proves Valid Surrogate Endpoint
    不详
    CANCER DISCOVERY, 2014, 4 (02) : 137 - 138
  • [8] Pathological complete response as a surrogate endpoint
    Sorscher, Steven
    BREAST, 2017, 33 : 202 - 202
  • [9] Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
    Redon, Josep
    Martinez, Fernando
    CURRENT HYPERTENSION REPORTS, 2012, 14 (04) : 345 - 349
  • [10] Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
    Josep Redon
    Fernando Martinez
    Current Hypertension Reports, 2012, 14 : 345 - 349